Dr. Derin Keskin is part of the Crazy 8 team studying a vaccine for childhood cancer predisposition syndromes.

Dr. Keskin is currently the principal scientist with the Translational Immunogenomics Lab at Harvard Medical School, teaching affiliate Dana-Farber Cancer Center. Keskin also serves as an affiliated associate professor at Denmark Technical Institute and an affiliated research scientist at the Broad Institute of MIT and Harvard.

Keskin’s research focuses on vaccine immunotherapies, autoimmune diseases, and cancer immunology. He has been involved with preclinical development, such as efficacy and safety studies, in vaccine research and has more than a decade of experience in T cell-based vaccine design against cancers and viruses such as influenza, HIV, and HPV. He has been an ad hoc reviewer for journals such as Nature Cancer, Annals of Oncology, Molecular Medicine, Journal of Immunological Methods, Advances in Clinical Chemistry, Neurotoxicity Research, Journal of Investigative Dermatology, and the European Academy of Dermatology and Venereology Journal.